Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,987 | 155 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $445.19 | 23 | $0 (2024) |
| Lilly USA, LLC | $284.81 | 17 | $0 (2024) |
| ABBVIE INC. | $241.81 | 12 | $0 (2024) |
| Daiichi Sankyo Inc. | $230.00 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $202.87 | 10 | $0 (2022) |
| GlaxoSmithKline, LLC. | $193.61 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $146.08 | 9 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $130.00 | 1 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $127.45 | 11 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $123.12 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $494.56 | 24 | Mylan Specialty L.P. ($105.73) |
| 2023 | $483.89 | 26 | ACADIA Pharmaceuticals Inc ($138.97) |
| 2022 | $445.39 | 26 | Lilly USA, LLC ($83.32) |
| 2021 | $362.98 | 22 | Lilly USA, LLC ($89.30) |
| 2020 | $275.30 | 16 | Sunovion Pharmaceuticals Inc. ($40.16) |
| 2019 | $601.68 | 26 | Daiichi Sankyo Inc. ($230.00) |
| 2018 | $192.13 | 13 | Teva Pharmaceuticals USA, Inc. ($127.45) |
| 2017 | $130.69 | 2 | ACADIA Pharmaceuticals Inc ($118.84) |
All Payment Transactions
155 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: RESPIRATORY | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: PAIN | ||||||
| 08/14/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/29/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 07/03/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/02/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PAIN | ||||||
| 06/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: PAIN | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.95 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: VACCINES | ||||||
| 03/05/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: OUD | ||||||
| 02/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Oncology | ||||||
| 02/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: PAIN | ||||||
| 12/11/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 447 | 1,041 | $112,060 | $59,080 |
| 2022 | 16 | 566 | 1,468 | $153,365 | $79,238 |
| 2021 | 18 | 586 | 1,659 | $165,615 | $102,685 |
| 2020 | 21 | 811 | 1,994 | $220,055 | $129,370 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 186 | $34,460 | $16,662 | 48.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 104 | $14,040 | $10,038 | 71.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 141 | $13,395 | $9,048 | 67.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 58 | $15,370 | $8,055 | 52.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 39 | 44 | $8,580 | $4,028 | 46.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 69 | $8,970 | $4,002 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 19 | $4,750 | $2,739 | 57.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $2,655 | $1,557 | 58.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 89 | $2,670 | $913.68 | 34.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 39 | 52 | $1,300 | $656.00 | 50.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 38 | 54 | $1,080 | $495.04 | 45.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 41 | $1,230 | $445.52 | 36.2% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 15 | 16 | $1,040 | $343.68 | 33.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 18 | 60 | $600.00 | $65.05 | 10.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 12 | 96 | $1,920 | $32.44 | 1.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 305 | $56,425 | $27,670 | 49.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 53 | 163 | $22,005 | $13,589 | 61.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 66 | $17,490 | $10,646 | 60.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 36 | 146 | $13,870 | $8,476 | 61.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 108 | $14,040 | $6,929 | 49.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 44 | 47 | $9,165 | $3,994 | 43.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 22 | $5,500 | $2,829 | 51.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 37 | 129 | $3,870 | $1,435 | 37.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 52 | 67 | $1,675 | $874.75 | 52.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 17 | $1,620 | $820.81 | 50.7% |
About Dr. Ayman Daoud, MD
Dr. Ayman Daoud, MD is a Internal Medicine healthcare provider based in Canton, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1073640355.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ayman Daoud, MD has received a total of $2,987 in payments from pharmaceutical and medical device companies, with $494.56 received in 2024. These payments were reported across 155 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,987).
As a Medicare-enrolled provider, Daoud has provided services to 2,410 Medicare beneficiaries, totaling 6,162 services with total Medicare billing of $370,374. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Canton, MI
- Active Since 02/27/2007
- Last Updated 02/25/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073640355
Products in Payments
- NUPLAZID (Drug) $445.19
- INJECTAFER (Drug) $230.00
- UBRELVY (Drug) $143.61
- NURTEC ODT (Drug) $137.34
- TRULICITY (Drug) $130.52
- LIBTAYO (Biological) $130.00
- TRELEGY ELLIPTA (Drug) $120.02
- YUPELRI (Drug) $105.73
- QULIPTA (Drug) $89.16
- AJOVY (Drug) $80.38
- ENTRESTO (Drug) $79.10
- Mavenclad (Biological) $73.19
- EMGALITY (Drug) $73.18
- ELIQUIS (Drug) $66.78
- TROKENDI XR (Drug) $64.08
- FARXIGA (Drug) $63.54
- MOUNJARO (Drug) $63.05
- XARELTO (Drug) $58.81
- LONHALA MAGNAIR (Drug) $56.64
- GEMTESA (Drug) $56.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Canton
Yevgeniy Bukhman, Do, DO
Internal Medicine — Payments: $128,107
Dr. Paul Tejera, M.d, M.D
Internal Medicine — Payments: $68,433
Muhammad Sardar, M.d, M.D
Internal Medicine — Payments: $61,752
Dr. Eyal Kedar, M.d, M.D
Internal Medicine — Payments: $43,999
Stacey Hollaway, Md, MD
Internal Medicine — Payments: $17,932
Ramal Weragoda, M.d, M.D
Internal Medicine — Payments: $17,604